PAPER Acharya M, Deo RC, Barua PD, Devi A, Tao X
SEARCH RESULTS
1770 RESULTS
PAPER Singh P, Kadam NY, Panigrahi R, Mehrotra A, Upadhayay K, Dey M, Tyagi A, Aquib M, Nielsen J, Kleijwegt G, Singh P, Sharma A, Rao A, Otzen DE, Kumar A, Sharma D
Sulfamerazine as a Potential Modulator against α-Synuclein Aggregation and Associated Toxicity.
ACS Chem Neurosci. 2025 Mar 5;16(5):880-894. Epub 2025 Feb 12 PubMed.PAPER Lonkar N, Latz E, McManus RM
Neuroinflammation and immunometabolism in neurodegenerative diseases.
Curr Opin Neurol. 2025 Apr 1;38(2):163-171. Epub 2025 Feb 12 PubMed.PAPER Zhu Y, Tian M, Lu S, Qin Y, Zhao T, Shi H, Li Z, Qin D
The antioxidant role of aromatic plant extracts in managing neurodegenerative diseases: A comprehensive review.
Brain Res Bull. 2025 Mar;222:111253. Epub 2025 Feb 10 PubMed.PAPER Krinsky-McHale SJ, Kovacs CM, Lee JH, Listwan TA, Pang DI, Schupf N, Tycko B, Zigman WB, Silverman W
Validity of one-time assessments for identifying prodromal Alzheimer's disease in adults with Down syndrome.
Alzheimers Dement (Amst). 2025;17(1):e70076. Epub 2025 Feb 11 PubMed.PAPER García-Alba J, Molanes-López EM, Zuluaga P, Bell-Fenellos C, Vaquero L, Alfayate E, García F, Mateo G, Modenhauer F, Galván-Román JM, Bajo R, Fernández A
Cognitive markers for the distinction between asymptomatic and prodromal Alzheimer's disease in Down syndrome: Correlations with volumetric brain changes.
Alzheimers Dement (Amst). 2025;17(1):e70084. Epub 2025 Feb 11 PubMed.Laykea Tafesse
Merck, United States
SORL1 c.3050-2179G> A
MUTATIONS SORL1 121564761 GRCh38/hg38 rs9665907 G A 121435470 GRCh37/hg19 rs9665907 G A Intron 21 Non-Coding c.3050-2179G>A Alzheimer's Disease This variant is one of 31 intronic variants in SORL1 that compose a haplotype associated with a reduced risk of A
SORL1 c.3050-2062T> C
MUTATIONS SORL1 121564878 GRCh38/hg38 rs11218343 T C 121435587 GRCh37/hg19 rs11218343 T C Intron 21 Non-Coding c.3050-2062T>C Alzheimer's Disease This variant is one of 31 intronic variants in SORL1 that compose a haplotype associated with a reduced risk of
SORL1 c.3050-1379G> T
MUTATIONS SORL1 121565561 GRCh38/hg38 rs3781832 G T 121436270 GRCh37/hg19 rs3781832 G T Intron 21 Non-Coding c.3050-1379G>T Alzheimer's Disease This variant is one of 31 intronic variants in SORL1 that compose a haplotype associated with a reduced risk of A
SORL1 Haplotype A
MUTATIONS SORL1 Chromosome 11 Non-Coding Haplotype A This haplotype, composed of 31 intronic variants in SORL1, was found to be associated with a reduced risk of Alzheimer’s disease and with certain AD-related endophenotypes in people of East Asian ancestry (Zhou e
Michael Haney, Sydney Mason on Expunging Microglial Lipid Droplets Boosts Phagocytosis
COMMENT In this study Wu et al. make an important contribution to a trajectory of recent papers on the damaging role of lipid-droplet-accumulating microglia (LDAM). In 2020, transcriptomic and functional studies of LDAM in the aged mouse brain established this mi
SORL1 c.3815-84G> A
MUTATIONS SORL1 121587936 GRCh38/hg38 rs17125497 G A 121458645 GRCh37/hg19 rs17125497 G A Intron 27 Non-Coding c.3815-84G>A Alzheimer's Disease This variant is one of 31 intronic variants in SORL1 that compose a haplotype associated with a reduced risk of A
SORL1 c.3707-275C> G
MUTATIONS SORL1 121585947 GRCh38/hg38 rs73595281 C G 121456656 GRCh37/hg19 rs73595281 C G Intron 26 Non-Coding c.3707-275C>G Alzheimer's Disease This variant is one of 31 intronic variants in SORL1 that compose a haplotype associated with a reduced risk of
SORL1 c.3707-870G> A
MUTATIONS SORL1 121585352 GRCh38/hg38 rs117807585 G A 121456061 GRCh37/hg19 rs117807585 G A Intron 26 Non-Coding c.3707-870G>A Alzheimer's Disease This variant is one of 31 intronic variants in SORL1 that compose a haplotype associated with a reduced risk o
Current Filters
- Date Range : Feb 2025 to Mar 2025 x